Clinical Trials in Ireland 2026 — Live Tracker

Hip Fractures (ICD-10 72.01-72.2), Frailty at Older Adults, Strength Training, Resistance Training
Royal College of Surgeons, Ireland · started 2025-08-01

📍 Waterford

NCT07027241 on ClinicalTrials.gov ↗

Starting soon Phase 4

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Pulmonary Aspiration During Anaesthetic Induction, Gastric Emptying Time, Preoperative Risk Assessment, Obesity (Disorder)
Mater Misericordiae University Hospital · started 2025-08

📍 Dublin

NCT07100691 on ClinicalTrials.gov ↗

Recruiting

Harmony TPV EMEA PMS

Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular · started 2025-07-30

📍 Dublin

NCT06906926 on ClinicalTrials.gov ↗

Recruiting Phase 4

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

Hemophilia A
Swedish Orphan Biovitrum · started 2025-05-21

📍 Dublin

NCT06940830 on ClinicalTrials.gov ↗

Recruiting Phase 3

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
Revolution Medicines, Inc. · started 2025-05-06

📍 Cork · Dublin · Galway

NCT06881784 on ClinicalTrials.gov ↗

Active Phase 2

A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

Sickle Cell Disease
Agios Pharmaceuticals, Inc. · started 2025-05-01

📍 Dublin

NCT06924970 on ClinicalTrials.gov ↗

Recruiting

Extubation
University Health Network, Toronto · started 2025-04-14

📍 Castlebar · Cork · Dublin · Galway · Waterford

NCT06442930 on ClinicalTrials.gov ↗

Recruiting

Assessing Intellectual and Motor Outcomes in High-risk Infants

Cerebral Palsy, Cerebral Palsy (CP), Cerebral Palsy Children, High-risk Infants
University College Cork · started 2025-03-21

📍 Cork · Dublin

NCT06857539 on ClinicalTrials.gov ↗

Recruiting

Inter- and Intraindividual Variability of the Acute Glucose Response to Exercise in Healthy Adults and People Living With Type 1 Diabetes: A Cross-over Replicate Trial

Exercise, Healthy Participants, Glucose Variability, Type 1 Diabetes (T1D)
University College Dublin · started 2025-01-28

📍 Dublin

NCT07209930 on ClinicalTrials.gov ↗

Active

Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP)

Traumatic Spinal Cord Injury
University College Dublin · started 2024-12-20

📍 Dublin

NCT06463418 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.

Achondroplasia
Ascendis Pharma A/S · started 2024-12-10

📍 Dublin

NCT06732895 on ClinicalTrials.gov ↗

Recruiting Phase 3

Efficacy of INM004 in Children With STEC-HUS

Hemolytic-Uremic Syndrome
Inmunova S.A. · started 2024-10-05

📍 Dublin

NCT06389474 on ClinicalTrials.gov ↗

Recruiting

Microbiome Immunotherapy Neoadjuvant Assessment

Triple Negative Breast Cancer
University College Cork · started 2024-10-02

📍 Cork

NCT06709651 on ClinicalTrials.gov ↗

Recruiting

Implementation of a Standardized Algorithm for Coronary Calcification With Plaque Modification

Myocardial Ischaemia, Severely Calcified Coronary Stenoses, Coronary Calcification
Royal College of Surgeons, Ireland · started 2024-09-24

📍 Dublin

NCT06678594 on ClinicalTrials.gov ↗

Active

Safety and Tolerance of a Novel Three-Strain Probiotic in Healthy Adults

Healthy Adults
Pendulum Therapeutics · started 2024-09-23

📍 Cork

NCT07566884 on ClinicalTrials.gov ↗

Recruiting Phase 1

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
Eli Lilly and Company · started 2024-09-12

📍 Dublin

NCT06586515 on ClinicalTrials.gov ↗

Recruiting Phase 3

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Pulmonary Arterial Hypertension
Gossamer Bio USA, Inc. · started 2024-09-03

📍 Dublin

NCT06274801 on ClinicalTrials.gov ↗

By invitation

Sleep Well At Night

Sleep Disturbance in Advanced Cancer
Our Lady's Hospice and Care Services · started 2024-08-19

📍 Dublin

NCT07068971 on ClinicalTrials.gov ↗

Recruiting

A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy

Cerebral Palsy, Walking, Difficulty, Spastic Diplegia, Hemiplegic Cerebral Palsy
Royal College of Surgeons, Ireland · started 2024-08-12

📍 Balrath

NCT06454656 on ClinicalTrials.gov ↗

Recruiting

The Effect of a Post-operative Exercise Programme Versus Standard Care on Physical Fitness of Patients With Breast Cancer Undergoing Deep Inferior Epigastric Perforator (DIEP) Flap Reconstruction Surgery

Breast Cancer, Exercise
Royal College of Surgeons, Ireland · started 2024-08-01

📍 Beaumont

NCT07672392 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
AbbVie · started 2024-07-29

📍 Dublin

NCT06365853 on ClinicalTrials.gov ↗

Recruiting Phase 4

Fibrosis Lessens After Metabolic Surgery

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis
The Cleveland Clinic · started 2024-07-11

📍 Dublin

NCT06374875 on ClinicalTrials.gov ↗

By invitation

Prostate Cancer Awareness and Initiative for Screening in the European Union

Prostate Cancer
European Association of Urology Research Foundation · started 2024-06-01

📍 Dublin

NCT06424275 on ClinicalTrials.gov ↗

Active

Cognition in Older Adults With Cancer Receiving Systemic Anti-Cancer Therapy

Cancer, Older Adults (65 Years and Older), Cognition
Our Lady's Hospice and Care Services · started 2024-05-21

📍 Dublin

NCT07411105 on ClinicalTrials.gov ↗

Recruiting

A Randomised Control Clinical Trial Investigating the Effect of H-PRF on Implant Stability and Marginal Bone Levels

Osseointegration Failure of Dental Implant
University of Dublin, Trinity College · started 2024-05-17

📍 Dublin

NCT06453330 on ClinicalTrials.gov ↗

Recruiting

A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

Psychosis
University College Cork · started 2024-05-16

📍 Cork

NCT06729671 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cardiomyopathy, Hypertrophic
Bristol-Myers Squibb · started 2024-04-17

📍 Dublin 12, D12 N512

NCT06253221 on ClinicalTrials.gov ↗

Recruiting Phase 3

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Polycythemia Vera
Italfarmaco · started 2024-03-26

📍 Cork · Dublin

NCT06093672 on ClinicalTrials.gov ↗

Active Phase 2

A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Ulcerative Colitis
AbbVie · started 2024-03-23

📍 Elm Park · Dublin

NCT06257875 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

Achondroplasia
Ascendis Pharma A/S · started 2024-01-23

📍 Dublin

NCT06079398 on ClinicalTrials.gov ↗

Recruiting

Occupational Therapy-led Services for Adults Presenting Acutely With a Hand Condition

Hand Injuries
University of Limerick · started 2024-01-11

📍 Dublin · Galway · Limerick · Tipperary

NCT06399614 on ClinicalTrials.gov ↗

Recruiting

Affera Global Registry

Atrial Fibrillation
Medtronic Cardiac Ablation Solutions · started 2023-12-22

📍 Dublin

NCT06026345 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases

Solid Tumor Spine Metastases
Cancer Trials Ireland · started 2023-11-21

📍 Cork · Dublin

NCT06078813 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology · started 2023-11-14

📍 Dublin

NCT05658640 on ClinicalTrials.gov ↗

Recruiting Phase 3

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Non-Small Cell Lung Cancer
Summit Therapeutics · started 2023-10-26

📍 Dublin · Galway

NCT05899608 on ClinicalTrials.gov ↗

Active

Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Royal Marsden NHS Foundation Trust · started 2023-09-26

NCT06019676 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Hidradenitis Suppurativa
AbbVie · started 2023-06-21

📍 Dublin · Cork · Galway · Waterford

NCT05889182 on ClinicalTrials.gov ↗

Active

Bioavailability of Spermidine in Healthy Males

Healthy Subjects
Chrysea Labs Lda · started 2023-05-05

📍 Cork

NCT06017219 on ClinicalTrials.gov ↗

Active Phase 3

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Endometrial Cancer
Karyopharm Therapeutics Inc · started 2023-04-18

📍 Dublin · Cork · Galway · Waterford

NCT05611931 on ClinicalTrials.gov ↗

Active Phase 3

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
Day One Biopharmaceuticals, Inc. · started 2023-02-27

📍 Crumlin

NCT05566795 on ClinicalTrials.gov ↗

Active Phase 3

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Melanoma
Regeneron Pharmaceuticals · started 2023-01-16

📍 Galway · Cork · Dublin

NCT05608291 on ClinicalTrials.gov ↗

Recruiting

AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)

Coronary Artery Disease (CAD), Computed Tomography Angiography, Biomarkers, AI (Artificial Intelligence)
University of Galway · started 2022-12-21

📍 Galway

NCT07577609 on ClinicalTrials.gov ↗

Recruiting Phase 2

Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants

Patent Ductus Arteriosus After Premature Birth
Mount Sinai Hospital, Canada · started 2022-12-12

📍 Dublin

NCT05340582 on ClinicalTrials.gov ↗

Recruiting Phase 3

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Triple Negative Breast Cancer
Gilead Sciences · started 2022-12-12

📍 Dublin · Limerick · Wilton

NCT05633654 on ClinicalTrials.gov ↗

Active Phase 1/Phase 2

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Duchenne Muscular Dystrophy (DMD)
Dyne Therapeutics · started 2022-08-12

📍 Dublin

NCT05524883 on ClinicalTrials.gov ↗

Active Phase 3

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Multiple Myeloma
Celgene · started 2022-06-23

📍 Cork · Dublin · Galway

NCT04975997 on ClinicalTrials.gov ↗

Recruiting Phase 3

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Prostate Cancer Metastatic
UNICANCER · started 2022-04-19

📍 Dublin · Limerick

NCT04916613 on ClinicalTrials.gov ↗

Recruiting Phase 3

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Hodgkin Lymphoma
University College, London · started 2022-04-14

📍 Dublin · Galway

NCT04685616 on ClinicalTrials.gov ↗

Active Phase 2

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma
Cancer Trials Ireland · started 2022-04-01

📍 Dublin · Waterford

NCT05123131 on ClinicalTrials.gov ↗

Recruiting

Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological Analyses

Glioblastoma
Patrick Morris · started 2022-03-01

📍 Beaumont

NCT07731555 on ClinicalTrials.gov ↗

Active

Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

Metabolic Disease, Obesity & Overweight
University College Dublin · started 2022-02-17

📍 Dublin

NCT07457424 on ClinicalTrials.gov ↗

Active Phase 2

Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)

PIK3CA-related Overgrowth Spectrum (PROS)
Novartis Pharmaceuticals · started 2022-01-27

📍 Dublin

NCT04980833 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC, 1st Line NSCLC
Synthekine · started 2022-01-25

📍 Dublin · Galway

NCT05098132 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis
Blueprint Medicines Corporation · started 2021-11-30

📍 Cork

NCT04910685 on ClinicalTrials.gov ↗

Active Phase 3

A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Primary Immune Thrombocytopenia
argenx · started 2021-11-17

📍 Dublin

NCT04812925 on ClinicalTrials.gov ↗

Active Phase 3

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company · started 2021-10-27

📍 Dublin

NCT04988386 on ClinicalTrials.gov ↗

Active

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular · started 2021-10-20

📍 Dublin

NCT05198674 on ClinicalTrials.gov ↗

Active Phase 3

A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Loxo Oncology, Inc. · started 2021-09-20

📍 Dublin · Waterford

NCT04965493 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
Medicenna Therapeutics, Inc. · started 2021-08-27

📍 Dublin

NCT05086692 on ClinicalTrials.gov ↗

Recruiting

Trial-Ready Cohort-Down Syndrome (TRC-DS)

Down Syndrome, Alzheimer Disease, Dementia
University of Southern California · started 2021-06-07

📍 Dublin

NCT04165109 on ClinicalTrials.gov ↗

Recruiting

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

Kidney Disease, End-Stage, End-stage Renal Disease, Arteriovenous Fistula
C. R. Bard · started 2021-03-26

NCT04634916 on ClinicalTrials.gov ↗

Active Phase 3

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Loxo Oncology, Inc. · started 2021-03-09

📍 Dublin

NCT04666038 on ClinicalTrials.gov ↗

Recruiting Phase 3

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome
Ottawa Hospital Research Institute · started 2021-02-10

📍 Dublin

NCT04319627 on ClinicalTrials.gov ↗

Recruiting

iCorMicA - Stratified Medicine in Angina

Microvascular Angina, Angina, Stable, Ischemia With No Obstructive Coronary Arteries (INOCA), Coronary Microvascular Dysfunction (CMD)
NHS Greater Glasgow and Clyde · started 2020-12-30

📍 Cork · Dublin

NCT04674449 on ClinicalTrials.gov ↗

Active Phase 3

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

HER2-negative Breast Cancer, Triple Negative Breast Cancer
GBG Forschungs GmbH · started 2020-10-28

📍 Cork · Dublin · Limerick · Waterford

NCT04595565 on ClinicalTrials.gov ↗

Active Phase 3

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

Paroxysmal Nocturnal Hemoglobinuria
Hoffmann-La Roche · started 2020-09-30

📍 Dublin

NCT04432584 on ClinicalTrials.gov ↗

Active Phase 1/Phase 2

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Select Advanced Solid Tumors
Immunocore Ltd · started 2020-02-25

📍 Dublin

NCT04262466 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Hypertension, Pulmonary
Actelion · started 2020-01-16

📍 Dublin

NCT04175600 on ClinicalTrials.gov ↗

Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Cutaneous Melanoma, Stage II
Melanoma and Skin Cancer Trials Limited · started 2019-12-17

📍 Cork · Dublin

NCT03860883 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb · started 2019-11-05

📍 Dublin

NCT04025879 on ClinicalTrials.gov ↗

Recruiting Phase 2

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica · started 2019-10-09

📍 Dublin

NCT04793919 on ClinicalTrials.gov ↗

Active Phase 2/Phase 3

A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis
Janssen Research & Development, LLC · started 2019-09-26

📍 Dublin · Galway

NCT04033445 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer
Bristol-Myers Squibb · started 2019-08-05

📍 Dublin · Limerick

NCT04008030 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Ulcerative Colitis
Eli Lilly and Company · started 2018-07-18

📍 Dublin

NCT03519945 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Progressive Multiple Sclerosis (PMS)
Hoffmann-La Roche · started 2018-05-28

📍 Cork · Dublin

NCT03523858 on ClinicalTrials.gov ↗

Active

Pyruvate Kinase Deficiency Global Longitudinal Registry

Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc. · started 2018-04-23

📍 Dublin

NCT03481738 on ClinicalTrials.gov ↗

Active Phase 3

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology · started 2018-02-01

📍 Dublin

NCT03367702 on ClinicalTrials.gov ↗

Active

ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population

Primary Knee Arthroplasty
DePuy Orthopaedics · started 2017-09-19

📍 Cork

NCT03153449 on ClinicalTrials.gov ↗

Recruiting

Registry for Patients With X-Linked Hypophosphatemia

X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd · started 2017-09-12

📍 Dublin

NCT03193476 on ClinicalTrials.gov ↗

Active

The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)

Ischaemic Heart Disease, Ischemic Heart Disease
Aarhus University Hospital Skejby · started 2017-07-05

📍 Galway

NCT03171311 on ClinicalTrials.gov ↗

Active

Optimal Nutrition for Prevention of Hypertension in Pregnancy

Blood Pressure, Pregnancy
University of Ulster · started 2017-03-01

📍 Letterkenny

NCT04723836 on ClinicalTrials.gov ↗

Recruiting

The Biomechanical Study of Diseased Human Carotid, Femoral and Abdominal Aortic Tissue

Vascular Diseases
University Hospital of Limerick · started 2016-01-01

📍 Limerick

NCT05802706 on ClinicalTrials.gov ↗

Active Phase 3

Phase III Radium 223 mCRPC-PEACE III

Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC · started 2015-10

📍 Cork · Dublin

NCT02194842 on ClinicalTrials.gov ↗

Active

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

Crohn's Disease
AbbVie · started 2014-08-28

📍 Manorhamilton

NCT02130362 on ClinicalTrials.gov ↗

Active Phase 2/Phase 3

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Brain Tumors
Universitätsklinikum Hamburg-Eppendorf · started 2014-06

📍 Dublin

NCT02066220 on ClinicalTrials.gov ↗

Active Phase 3

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Prostatic Neoplasms
University of Sydney · started 2014-03

📍 Cork · Galway · Dublin

NCT02446444 on ClinicalTrials.gov ↗

Active Phase 3

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Prostatic Neoplasms
University of Sydney · started 2014-03

📍 Beaumont · Dublin · Galway · Tallaght · Waterford

NCT02446405 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC · started 2013-09-09

📍 Dublin

NCT01804686 on ClinicalTrials.gov ↗

Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry

Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc. · started 2013-05-30

📍 Dublin

NCT01633489 on ClinicalTrials.gov ↗

By invitation

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

Legg Calve Perthes Disease
Texas Scottish Rite Hospital for Children · started 2012-08

📍 Dublin

NCT02040714 on ClinicalTrials.gov ↗

Recruiting

Product Surveillance Registry

Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic · started 2012-01

📍 Galway

NCT01524276 on ClinicalTrials.gov ↗